Impact Biomedical Stock Alpha and Beta Analysis

IBO Stock  USD 0.46  0.01  2.06%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Impact BioMedical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Impact BioMedical over a specified time horizon. Remember, high Impact BioMedical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Impact BioMedical's market risk premium analysis include:
Beta
0.73
Alpha
(0.18)
Risk
7.56
Sharpe Ratio
(0.01)
Expected Return
(0.09)
Please note that although Impact BioMedical alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Impact BioMedical did 0.18  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Impact BioMedical stock's relative risk over its benchmark. Impact BioMedical has a beta of 0.73  . As returns on the market increase, Impact BioMedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical is expected to be smaller as well. As of the 26th of January 2026, Book Value Per Share is likely to drop to 0.14. In addition to that, Tangible Book Value Per Share is likely to drop to -0.24.

Impact BioMedical Quarterly Cash And Equivalents

12,000

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Impact BioMedical Backtesting, Impact BioMedical Valuation, Impact BioMedical Correlation, Impact BioMedical Hype Analysis, Impact BioMedical Volatility, Impact BioMedical History and analyze Impact BioMedical Performance.
To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.

Impact BioMedical Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Impact BioMedical market risk premium is the additional return an investor will receive from holding Impact BioMedical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Impact BioMedical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Impact BioMedical's performance over market.
α-0.18   β0.73

Impact BioMedical expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Impact BioMedical's Buy-and-hold return. Our buy-and-hold chart shows how Impact BioMedical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Impact BioMedical Market Price Analysis

Market price analysis indicators help investors to evaluate how Impact BioMedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Impact BioMedical shares will generate the highest return on investment. By understating and applying Impact BioMedical stock market price indicators, traders can identify Impact BioMedical position entry and exit signals to maximize returns.

Impact BioMedical Return and Market Media

The median price of Impact BioMedical for the period between Tue, Oct 28, 2025 and Mon, Jan 26, 2026 is 0.5 with a coefficient of variation of 10.02. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 0.5, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Why Impact BioMedical Inc. stock stays resilient - Short Setup AI Enhanced Trade Execution Alerts - newser.com
11/04/2025
2
Is Impact BioMedical Inc. stock dividend yield sustainable - Earnings Recap Report Real-Time Volume Triggers - newser.com
11/07/2025
3
Why Impact BioMedical Inc. stock stays resilient - 2025 Pullback Review Reliable Breakout Forecasts - newser.com
11/11/2025
4
How Impact BioMedical Inc. stock reacts to inflationary pressures - July 2025 Trends Safe Investment Capital Preservation Plans - newser.com
11/14/2025
5
Will Impact BioMedical Inc. stock deliver compounding returns - 2025 Geopolitical Influence Growth Focused Entry Reports - newser.com
11/19/2025
6
Will Impact BioMedical Inc. stock benefit from sector rotation - 2025 Trade Ideas Stock Portfolio Risk Management - Newser
12/04/2025
7
Insider Trading
12/26/2025
8
Disposition of 47681 shares by Dss, Inc. of Impact BioMedical at 2.5011 subject to Rule 16b-3
01/02/2026
9
How Impact BioMedical Inc. stock responds to policy changes - Quarterly Investment Review Expert-Curated Trade Recommendations - ulpravda.ru
01/08/2026
10
Acquisition by Dss, Inc. of 7800 shares of Impact BioMedical at 2.4 subject to Rule 16b-3
01/16/2026
11
EPS Watch Whats the fair value of Impact BioMedical Inc stock - Quarterly Market Summary Capital Efficiency Focused Strategies - baoquankhu1.vn
01/20/2026

About Impact BioMedical Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Impact or other stocks. Alpha measures the amount that position in Impact BioMedical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2025 2026 (projected)
Days Sales Outstanding28.8125.9323.05
PTB Ratio14.2212.7911.38
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Impact BioMedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Impact BioMedical's short interest history, or implied volatility extrapolated from Impact BioMedical options trading.

Build Portfolio with Impact BioMedical

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Impact BioMedical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Impact BioMedical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Impact Biomedical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Impact Biomedical Stock:
Check out Impact BioMedical Backtesting, Impact BioMedical Valuation, Impact BioMedical Correlation, Impact BioMedical Hype Analysis, Impact BioMedical Volatility, Impact BioMedical History and analyze Impact BioMedical Performance.
To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Impact BioMedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Impact BioMedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Impact BioMedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...